Tanja Reuter, Ph.D.: Difference between revisions
From OpenWetWare
Jump to navigationJump to search
m (Hoatlin:Tanja Reuter, Ph.D. moved to Tanja Reuter, Ph.D.) |
No edit summary |
||
| Line 9: | Line 9: | ||
identifies new ideas for potential therapeutic targets. She and her | identifies new ideas for potential therapeutic targets. She and her | ||
husband Stefan, who is also a scientist, live in Germany with their | husband Stefan, who is also a scientist, live in Germany with their | ||
daughter, Nike, | daughter, Nike, and a son, born in June 2007. | ||
Return to Main Page [[Hoatlin Lab]] | Return to Main Page [[Hoatlin Lab]] | ||
Revision as of 08:14, 14 June 2007
Tanja Reuter was a DFG postdoctoral fellow from 2001-2002. Tanja performed studies that were an essential foundation for the development of the Xenopus model for Fanconi anemia. Following her postdoctoral fellowship in the Hoatlin Lab she became a Staff Scientist at DeveloGen, a biotech company based in Germany. She is currently a Group Leader at Merck KGaA, in the Cardio-Metabolic Research Section. She directs the "New Concept Group", where she identifies new ideas for potential therapeutic targets. She and her husband Stefan, who is also a scientist, live in Germany with their daughter, Nike, and a son, born in June 2007.
Return to Main Page Hoatlin Lab
